Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00863395 · ClinicalTrials.gov registry record · Phase 1
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
A Phase 1 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00863395: Clinical Trial Phase 1 study, sponsored by University of Minnesota.
NCT00863395 is a Phase 1 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00863395, a Phase 1 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to define the mechanisms that underlie the refractory pruritus (itch) in Cutaneous T-Cell Lymphoma (CTCL).
Interventions
- PROCEDURE skin biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Why NCT00863395 stopped before completion
NCT00863395 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which skin biopsy is the first listed.
NCT00863395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00863395 about?
NCT00863395 is a clinical study titled "Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma". The purpose of this study is to define the mechanisms that underlie the refractory pruritus (itch) in Cutaneous T-Cell Lymphoma (CTCL).
What is the current status of trial NCT00863395?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00863395?
The interventions under investigation include: skin biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00863395?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00863395's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia